Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-03-10
1999-12-21
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 48, A61K 3154, C07D51304
Patent
active
060049545
ABSTRACT:
This invention relates to a compound of the following formula or a salt thereof, their production and use. ##STR1## wherein R.sup.1 and R.sup.2 independently represent hydrogen, a group bonding through a carbon atom, a group bonding through a nitrogen atom, a group bonding through an oxygen atom, or a group bonding through a sulfur atom; R.sup.3 represents hydrogen, halogen, a group bonding through a carbon atom, a group bonding through a nitrogen atom, a group bonding through an oxygen atom, or a group bonding through a sulfur atom; W represents an oxygen atom or sulfur atom; A represents a group forming a nitrogen-containing condensed ring at the 3,4- of a 1,4-thiazine ring; R.sup.1 and R.sup.2 may be combined to form a bivalent hydrocarbon group interrupted by one or more hetero atoms or an alkylene group. The above compound or a salt thereof not only has Th1 and Th2 cell function modulating activity but has splenocyte proliferation response, interleukin-5 production, and interferon-gamma production inhibitory activity and finds application as an effective therapeutic and/or prophylactic agent for allergic or autoimmune diseases or as an effective therapeutic and/or prophylactic agent for graft rejection or graft-vs-host disease.
REFERENCES:
patent: 4315767 (1982-02-01), Wolf
Lafaille, "The Role of Helper T Cell Subsets in Autoimmune Diseases," Cytokine & Growth Factor Reviews, vol. 9, No. 2, pp. 139-151, Jun. 1998.
Ead et al., "Synthesis and Reactions of New 1,2,4-Triazoles and Their Biological Activities," Arch. Pharm., vol. 323, No. 1, pp. 57-58, 1990.
C.V. Reddy Sastry et al., "An improved synthesis of 2,4-dihydro-1-oxo-1,2,4]triazolo[3,4-c][1,4]-benzoxazines and -benzothiazines", Chemistry and Industry, 3, pp. 227-228, 1989.
D. Spinelli et al., "A new ring transformation: conversion of 6-p-chlorophenyl-3-methyl-5-nitrosoimidazo[2,1-b]thiazole into 8-p-chlorophenyl-8-hydroxy-5-methyl-3-oxo-1,2,4-oxadiazolo[3,4-c][1,4-]thi azine by the action of mineral acids", J. Chem. Soc. Chem. Commun., 19, pp. 1394-1395, 1992.
R. Mitra et al., "Synthesis of 1,2,4-triazolo fused heterocycels", Heterocycles, vol. 27, No. 10, pp. 2297-2300, 1988.
S.S. Tandon et al., "A structual reassignment: 5,8a-Diphenyl-2,3,8,8a-tetrahydro-1H-imidazo[2,1-c][1,4]thiazine", Synthesis, 6, pp. 481-482, 1983.
CAS online abstract of Khim. Geterotsikl., Soedin., 9, pp. 1211-20, 1979.
Furuya Shuichi
Ohta Yoshikazu
Tanida Seiichi
Kessinger Ann M.
Shah Mukund J.
Takeda Chemical Industries Ltd.
LandOfFree
Condensed thiazine derivatives, their production and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Condensed thiazine derivatives, their production and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Condensed thiazine derivatives, their production and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505308